These results showed that evodiamine attenuated colitis via the induction of autophagosome-mediated degradation of inflammasome and the inhibition of NFκB pathway, which synergistically contribute to the effect of evodiamine in colitis. The gene discussed is NFKB1; the disease is colitis.